Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toripalimab and Radiotherapy in MSS Metastatic Colorectal Cancer
NCT06525428Phase 2Recruiting
- Sponsor
- Fudan University
- Start
- Apr 2024
- Primary completion
- Dec 2026
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of toripalimab in colorectal cancer (metastatic) (mCRC), sponsored by Fudan University. Started Apr 2024; status: recruiting.
02
Drugs
toripalimab
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT06525428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06525428.